Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project.

Moreno-Grau S, de Rojas I, Hernández I, Quintela I, Montrreal L, Alegret M, Hernández-Olasagarre B, Madrid L, González-Perez A, Maroñas O, Rosende-Roca M, Mauleón A, Vargas L, Lafuente A, Abdelnour C, Rodríguez-Gómez O, Gil S, Santos-Santos MÁ, Espinosa A, Ortega G, Sanabria Á, Pérez-Cordón A, Cañabate P, Moreno M, Preckler S, Ruiz S, Aguilera N, Pineda JA, Macías J, Alarcón-Martín E, Sotolongo-Grau O; GR@ACE consortium; DEGESCO consortium; Alzheimer's Disease Neuroimaging Initiative, Marquié M, Monté-Rubio G, Valero S, Benaque A, Clarimón J, Bullido MJ, García-Ribas G, Pástor P, Sánchez-Juan P, Álvarez V, Piñol-Ripoll G, García-Alberca JM, Royo JL, Franco E, Mir P, Calero M, Medina M, Rábano A, Ávila J, Antúnez C, Real LM, Orellana A, Carracedo Á, Sáez ME, Tárraga L, Boada M, Ruiz A.

Alzheimers Dement. 2019 Aug 13. pii: S1552-5260(19)35117-9. doi: 10.1016/j.jalz.2019.06.4950. [Epub ahead of print]

2.

Visual impairment in aging and cognitive decline: experience in a Memory Clinic.

Marquié M, Castilla-Martí M, Valero S, Martínez J, Sánchez D, Hernández I, Rosende-Roca M, Vargas L, Mauleón A, Rodríguez-Gómez O, Abdelnour C, Gil S, Santos-Santos MA, Alegret M, Espinosa A, Ortega G, Pérez-Cordón A, Sanabria Á, Roberto N, Moreno-Grau S, de Rojas I, Simó R, Ciudin A, Hernández C, Orellana A, Monté-Rubio G, Benaque A, Ruiz A, Tárraga L, Boada M.

Sci Rep. 2019 Jun 18;9(1):8698. doi: 10.1038/s41598-019-45055-9.

3.

The MOPEAD project: Advancing patient engagement for the detection of "hidden" undiagnosed cases of Alzheimer's disease in the community.

Rodríguez-Gómez O, Rodrigo A, Iradier F, Santos-Santos MA, Hundemer H, Ciudin A, Sannemann L, Zwan M, Glaysher B, Wimo A, Bonn J, Johansson G, Rodriguez I, Alegret M, Gove D, Pinó S, Trigueros P, Kivipelto M, Mathews B, Ciudad A, Ferreira D, Bintener C, Gurruchaga M, Westman E, Belger M, Valero S, Maguire P, Krivec D, Kramberger M, Simó R, Garro IP, Visser PJ, Dumas A, Georges J, Jessen F, Winblad B, Shering C, Stewart N, Campo L, Boada M; MOPEAD Consortium.

Alzheimers Dement. 2019 Jun;15(6):828-839. doi: 10.1016/j.jalz.2019.02.003. Epub 2019 May 7. Review.

4.

Perovskite Solar Cells Based on Oligotriarylamine Hexaarylbenzene as Hole-Transporting Materials.

Shasti M, Völker SF, Collavini S, Valero S, Ruipérez F, Mortezaali A, Zakeeruddin SM, Grätzel M, Hagfeldt A, Delgado JL.

Org Lett. 2019 May 3;21(9):3261-3264. doi: 10.1021/acs.orglett.9b00988. Epub 2019 Apr 22.

PMID:
31007029
5.

KCa3.1 Transgene Induction in Murine Intestinal Epithelium Causes Duodenal Chyme Accumulation and Impairs Duodenal Contractility.

Valero MS, Ramón-Gimenez M, Lozano-Gerona J, Delgado-Wicke P, Calmarza P, Oliván-Viguera A, López V, Garcia-Otín ÁL, Valero S, Pueyo E, Hamilton KL, Miura H, Köhler R.

Int J Mol Sci. 2019 Mar 8;20(5). pii: E1193. doi: 10.3390/ijms20051193.

6.

[Non-programmed hospitalization of elderly patients with cancer: Which care pathway?]

Valero S, Simet G, Fauchier T, Jamet A, Bouchaert P, Migeot V, Tourani JM, Paccalin M, Liuu E.

Bull Cancer. 2019 Apr;106(4):293-303. doi: 10.1016/j.bulcan.2018.12.012. Epub 2019 Mar 1. French.

PMID:
30827485
7.

Immune Response and Intraocular Inflammation in Patients With Leber Hereditary Optic Neuropathy Treated With Intravitreal Injection of Recombinant Adeno-Associated Virus 2 Carrying the ND4 Gene: A Secondary Analysis of a Phase 1/2 Clinical Trial.

Bouquet C, Vignal Clermont C, Galy A, Fitoussi S, Blouin L, Munk MR, Valero S, Meunier S, Katz B, Sahel JA, Thomasson N.

JAMA Ophthalmol. 2019 Apr 1;137(4):399-406. doi: 10.1001/jamaophthalmol.2018.6902.

8.

Association Between Erectile Dysfunction and Carotid Subclinical Atherosclerosis in HIV-Infected Patients.

Bernal E, Torres M, Alcaraz A, Alcaraz MJ, Rosa V, Valero S, Muñoz A, Onteniente M, Vicente T, Cano A.

J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):429-435. doi: 10.1097/QAI.0000000000001932.

PMID:
30664536
9.

T cell senescence predicts subclinical atherosclerosis in HIV-infected patients similarly to traditional cardiovascular risk factors.

Bernal E, Martinez M, Torres A, Guillamón CF, Alcaraz A, Alcaraz MJ, Muñoz A, Valero S, Botella C, Campillo JA, Cano A, Minguela A.

Antiviral Res. 2019 Feb;162:163-170. doi: 10.1016/j.antiviral.2018.12.014. Epub 2018 Dec 26.

PMID:
30593833
10.

Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI).

de Rojas I, Romero J, Rodríguez-Gomez O, Pesini P, Sanabria A, Pérez-Cordon A, Abdelnour C, Hernández I, Rosende-Roca M, Mauleón A, Vargas L, Alegret M, Espinosa A, Ortega G, Gil S, Guitart M, Gailhajanet A, Santos-Santos MA, Moreno-Grau S, Sotolongo-Grau O, Ruiz S, Montrreal L, Martín E, Pelejà E, Lomeña F, Campos F, Vivas A, Gómez-Chiari M, Tejero MA, Giménez J, Pérez-Grijalba V, Marquié GM, Monté-Rubio G, Valero S, Orellana A, Tárraga L, Sarasa M, Ruiz A, Boada M; FACEHBI study.

Alzheimers Res Ther. 2018 Nov 29;10(1):119. doi: 10.1186/s13195-018-0444-1.

11.

Remittance or persistence of attention deficit-hyperactivity disorder (ADHD) and its impact on recidivism in risky driving behaviors.

Valero S, Bosch R, Corominas M, Barrau V, Ramos-Quiroga JA, Casas M.

Traffic Inj Prev. 2018;19(7):701-707. doi: 10.1080/15389588.2018.1505043. Epub 2018 Nov 28.

PMID:
30485128
12.

Exploring Genetic Associations of Alzheimer's Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes.

Espinosa A, Hernández-Olasagarre B, Moreno-Grau S, Kleineidam L, Heilmann-Heimbach S, Hernández I, Wolfsgruber S, Wagner H, Rosende-Roca M, Mauleón A, Vargas L, Lafuente A, Rodríguez-Gómez O, Abdelnour C, Gil S, Marquié M, Santos-Santos MA, Sanabria Á, Ortega G, Monté-Rubio G, Pérez A, Ibarria M, Ruiz S, Kornhuber J, Peters O, Frölich L, Hüll M, Wiltfang J, Luck T, Riedel-Heller S, Montrreal L, Cañabate P, Moreno M, Preckler S, Aguilera N, de Rojas I, Orellana A, Alegret M, Valero S, Nöthen MM, Wagner M, Jessen F, Tárraga L, Boada M, Ramírez A, Ruiz A.

Front Aging Neurosci. 2018 Oct 30;10:340. doi: 10.3389/fnagi.2018.00340. eCollection 2018.

13.

Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer's disease.

Sánchez D, Castilla-Marti M, Rodríguez-Gómez O, Valero S, Piferrer A, Martínez G, Martínez J, Serra J, Moreno-Grau S, Hernández-Olasagarre B, De Rojas I, Hernández I, Abdelnour C, Rosende-Roca M, Vargas L, Mauleón A, Santos-Santos MA, Alegret M, Ortega G, Espinosa A, Pérez-Cordón A, Sanabria Á, Ciudin A, Simó R, Hernández C, Villaoslada P, Ruiz A, Tàrraga L, Boada M.

Sci Rep. 2018 Nov 5;8(1):16345. doi: 10.1038/s41598-018-34577-3.

14.

Prevalence of cancer and management in elderly nursing home residents. A descriptive study in 45 French nursing homes.

Liuu E, Guyot N, Valero S, Jamet A, Ouazzani HE, Bouchaert P, Tourani JM, Migeot V, Paccalin M.

Eur J Cancer Care (Engl). 2019 Mar;28(2):e12957. doi: 10.1111/ecc.12957. Epub 2018 Oct 29.

PMID:
30370946
15.

Zeolite structure determination using genetic algorithms and geometry optimisation.

Liu X, Valero S, Argente E, Sastre G.

Faraday Discuss. 2018 Oct 26;211(0):103-115. doi: 10.1039/c8fd00035b.

PMID:
30039150
16.

Pre and post intervention study of antiblastic drugs contamination surface levels at a Pharmacy Department Compounding Area using a closed system drug transfer device and a decontamination process.

Valero S, López-Briz E, Vila N, Solana A, Melero M, Poveda JL.

Regul Toxicol Pharmacol. 2018 Jun;95:1-7. doi: 10.1016/j.yrtph.2018.03.001. Epub 2018 Mar 3.

PMID:
29510165
17.

The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in Subjective Cognitive Decline.

Sanabria A, Alegret M, Rodriguez-Gomez O, Valero S, Sotolongo-Grau O, Monté-Rubio G, Abdelnour C, Espinosa A, Ortega G, Perez-Cordon A, Gailhajanet A, Hernandez I, Rosende-Roca M, Vargas L, Mauleon A, Sanchez D, Martin E, Rentz DM, Lomeña F, Ruiz A, Tarraga L, Boada M; FACEHBI study group.

Sci Rep. 2018 Feb 28;8(1):3828. doi: 10.1038/s41598-018-21644-y.

18.

The Role of Verb Fluency in the Detection of Early Cognitive Impairment in Alzheimer's Disease.

Alegret M, Peretó M, Pérez A, Valero S, Espinosa A, Ortega G, Hernández I, Mauleón A, Rosende-Roca M, Vargas L, Rodríguez-Gómez O, Abdelnour C, Berthier ML, Bak TH, Ruíz A, Tárraga L, Boada M.

J Alzheimers Dis. 2018;62(2):611-619. doi: 10.3233/JAD-170826.

PMID:
29480180
19.

Safety of rAAV2/2-ND4 Gene Therapy for Leber Hereditary Optic Neuropathy.

Vignal C, Uretsky S, Fitoussi S, Galy A, Blouin L, Girmens JF, Bidot S, Thomasson N, Bouquet C, Valero S, Meunier S, Combal JP, Gilly B, Katz B, Sahel JA.

Ophthalmology. 2018 Jun;125(6):945-947. doi: 10.1016/j.ophtha.2017.12.036. Epub 2018 Feb 14. No abstract available.

20.

Food words distract the hungry: Evidence of involuntary semantic processing of task-irrelevant but biologically-relevant unexpected auditory words.

Parmentier FBR, Pacheco-Unguetti AP, Valero S.

PLoS One. 2018 Jan 4;13(1):e0190644. doi: 10.1371/journal.pone.0190644. eCollection 2018.

21.

Usefulness of midregional pro-adrenomedullin as a marker of organ damage and predictor of mortality in patients with sepsis.

Bernal-Morell E, García-Villalba E, Vera MDC, Medina B, Martinez M, Callejo V, Valero S, Cinesi C, Piñera P, Alcaraz A, Marin I, Muñoz A, Cano A.

J Infect. 2018 Mar;76(3):249-257. doi: 10.1016/j.jinf.2017.12.003. Epub 2017 Dec 12.

PMID:
29246637
22.

FACEHBI: A Prospective Study of Risk Factors, Biomarkers and Cognition in a Cohort of Individuals with Subjective Cognitive Decline. Study Rationale and Research Protocols.

Rodriguez-Gomez O, Sanabria A, Perez-Cordon A, Sanchez-Ruiz D, Abdelnour C, Valero S, Hernandez I, Rosende-Roca M, Mauleon A, Vargas L, Alegret M, Espinosa A, Ortega G, Guitart M, Gailhajanet A, Sotolongo-Grau O, Moreno-Grau S, Ruiz S, Tarragona M, Serra J, Martin E, Peleja E, Lomeña F, Campos F, Vivas A, Gomez-Chiari M, Tejero MA, Giménez J, Pesini P, Sarasa M, Martinez G, Ruiz A, Tarraga L, Boada M.

J Prev Alzheimers Dis. 2017;4(2):100-108. doi: 10.14283/jpad.2016.122.

PMID:
29186280
23.

Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results.

Moreno-Grau S, Rodríguez-Gómez O, Sanabria Á, Pérez-Cordón A, Sánchez-Ruiz D, Abdelnour C, Valero S, Hernández I, Rosende-Roca M, Mauleón A, Vargas L, Lafuente A, Gil S, Santos-Santos MÁ, Alegret M, Espinosa A, Ortega G, Guitart M, Gailhajanet A, de Rojas I, Sotolongo-Grau Ó, Ruiz S, Aguilera N, Papasey J, Martín E, Peleja E; Alzheimer's Disease Neuroimaging Initiative, Lomeña F, Campos F, Vivas A, Gómez-Chiari M, Tejero MÁ, Giménez J, Serrano-Ríos M, Orellana A, Tárraga L, Ruiz A, Boada M; FACEHBI study group.

Alzheimers Dement. 2018 May;14(5):634-643. doi: 10.1016/j.jalz.2017.10.005. Epub 2017 Nov 20.

24.

Different patterns of in-stent coverage in drug-eluting stents.

Gemma D, Valero SJ, Gómez RM, Córdoba FJI, Colunga PM, López-Sendón JL.

Rev Port Cardiol. 2017 Nov;36(11):873-874. doi: 10.1016/j.repc.2017.01.011. Epub 2017 Nov 8. English, Portuguese. No abstract available.

25.

Social Representation of Dementia: An Analysis of 5,792 Consecutive Cases Evaluated in a Memory Clinic.

Cañabate P, Martínez G, Rosende-Roca M, Moreno M, Preckler S, Valero S, Sotolongo O, Hernández I, Alegret M, Ortega G, Espinosa A, Mauleón A, Vargas L, Rodríguez O, Abdelnour C, Sánchez D, Martín E, Ruiz A, Tárraga L, Boada M.

J Alzheimers Dis. 2017;58(4):1099-1108. doi: 10.3233/JAD-161119.

26.

The N-terminal pro brain natriuretic peptide is the best predictor of mortality during hospitalization in patients with low risk of sepsis-related organ failure.

García Villalba E, Bernal Morell E, Egea MP, Marín I, Alcaraz Garcia A, Muñoz A, Vera M, Valero S, Martinez M, Callejo Hurtado V, Gomez Verdu JM, Santo A, Cano Sanchez A.

Med Clin (Barc). 2017 Sep 8;149(5):189-195. doi: 10.1016/j.medcli.2017.02.036. Epub 2017 May 2. English, Spanish.

PMID:
28473224
27.

Cigarette dependence and depressive symptoms as predictors of smoking status at five-year follow-up after a workplace smoking cessation program.

Nieva G, Comín M, Valero S, Bruguera E.

Addict Behav. 2017 Oct;73:9-15. doi: 10.1016/j.addbeh.2017.04.003. Epub 2017 Apr 3.

PMID:
28431293
28.

Psychopathology and traffic violations in subjects who have lost their driving license.

Valero S, Bosch R, Corominas M, Giannoni A, Barrau V, Ramos-Quiroga JA, Casas M.

Compr Psychiatry. 2017 Jul;76:45-55. doi: 10.1016/j.comppsych.2017.03.012. Epub 2017 Mar 28.

PMID:
28411408
29.

Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.

Espinosa A, Alegret M, Pesini P, Valero S, Lafuente A, Buendía M, San José I, Ibarria M, Tejero MA, Giménez J, Ruiz S, Hernández I, Pujadas F, Martínez-Lage P, Munuera J, Arbizu J, Tárraga L, Hendrix SB, Ruiz A, Becker JT, Landau SM, Sotolongo-Grau O, Sarasa M, Boada M; AB255 Study Group; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2017;57(2):447-459. doi: 10.3233/JAD-161223.

30.

Impact of Recruitment Methods in Subjective Cognitive Decline.

Abdelnour C, Rodríguez-Gómez O, Alegret M, Valero S, Moreno-Grau S, Sanabria Á, Hernández I, Rosende-Roca M, Vargas L, Mauleón A, Sánchez D, Espinosa A, Ortega G, Pérez-Cordón A, Diego S, Gailhajanet A, Guitart M, Sotolongo-Grau Ó, Ruiz A, Tárraga L, Boada M.

J Alzheimers Dis. 2017;57(2):625-632. doi: 10.3233/JAD-160915.

PMID:
28269773
31.

Gender Differences in Demographic and Clinical Features of Physicians Admitted to a Program for Medical Professionals with Mental Disorders.

Braquehais MD, Arrizabalaga P, Lusilla P, Valero S, Bel MJ, Bruguera E, Sher L, Casas M.

Front Psychiatry. 2016 Nov 25;7:181. eCollection 2016.

32.

Organic and perovskite solar cells: Working principles, materials and interfaces.

Marinova N, Valero S, Delgado JL.

J Colloid Interface Sci. 2017 Feb 15;488:373-389. doi: 10.1016/j.jcis.2016.11.021. Epub 2016 Nov 11. Review.

PMID:
27871725
33.

Study of prevalence of Personality Disorders in inmate men sample with Substance Use Disorders using of PDQ-4+ Self-Report.

Calvo N, Nasillo V, Ferrer M, Valero S, Perez-Conill Rde S, Rovira-Machordom M, Molina-Fernandez M, Casas M.

Actas Esp Psiquiatr. 2016 Sep;44(5):178-82. Epub 2016 Sep 1.

34.

Borderline Personality Disorder and Personality Inventory for DSM-5 (PID-5): Dimensional personality assessment with DSM-5.

Calvo N, Valero S, Sáez-Francàs N, Gutiérrez F, Casas M, Ferrer M.

Compr Psychiatry. 2016 Oct;70:105-11. doi: 10.1016/j.comppsych.2016.07.002. Epub 2016 Jul 5.

PMID:
27624429
35.

Psychometric Properties and Normative Data of the Zuckerman-Kuhlman Personality Questionnaire in a Psychiatric Outpatient Sample.

Martínez Ortega Y, Gomà-I-Freixanet M, Valero S.

J Pers Assess. 2017 Mar-Apr;99(2):219-224. doi: 10.1080/00223891.2016.1217419. Epub 2016 Sep 6.

PMID:
27598792
36.

Impulsive clinical profile of Borderline Personality Disorder with comorbid Substance Use Disorder.

Calvo N, Valero S, Ferrer M, Barral C, Casas M.

Actas Esp Psiquiatr. 2016 Jul;44(4):145-52. Epub 2016 Jul 1.

37.

Adolescents with Cancer and Occupational Deprivation in Hospital Settings: A Qualitative Study.

Miralles PM, Ramón NC, Valero SA.

Hong Kong J Occup Ther. 2016 Jun;27(1):26-34. doi: 10.1016/j.hkjot.2016.05.001. Epub 2016 Jun 10.

38.

Cortisol awakening response in adults with attention deficit hyperactivity disorder: Subtype differences and association with the emotional lability.

Ramos-Quiroga JA, Corominas-Roso M, Palomar G, Ferrer R, Valero S, Corrales M, Richarte V, Casas M.

Eur Neuropsychopharmacol. 2016 Jul;26(7):1140-9. doi: 10.1016/j.euroneuro.2016.03.014. Epub 2016 Apr 12.

PMID:
27084305
39.

Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease.

Ibarria M, Alegret M, Valero S, Morera A, Guitart M, Cañabate P, Moreno M, Lara S, Diego S, Hernández J, Tantinyá N, Vera M, Hernández I, Becker JT, Ruíz A, Boada M, Tárraga L.

J Alzheimers Dis. 2016;50(2):559-66. doi: 10.3233/JAD-150455.

40.

Concordance between Subjective and Objective Memory Impairment in Volunteer Subjects.

Alegret M, Rodríguez O, Espinosa A, Ortega G, Sanabria A, Valero S, Hernández I, Rosende-Roca M, Vargas L, Abdelnour C, Mauleón A, Gailhajanet A, Martín E, Tárraga L, Rentz DM, Amariglio RE, Ruíz A, Boada M.

J Alzheimers Dis. 2015;48(4):1109-17. doi: 10.3233/JAD-150594.

PMID:
26444795
41.

Reply to the Letter to the Editor: 'Depression symptoms in burn patients'.

Giannoni-Pastor A, Valero S, Gomà-I-Freixanet M, Arguello JM, Kinori GF, Casas M.

Burns. 2015 Dec;41(8):1895-1896. doi: 10.1016/j.burns.2015.05.015. Epub 2015 Sep 26. No abstract available.

PMID:
26404706
42.

Influence of Sampling and Recruitment Methods in Studies of Subjective Cognitive Decline.

Rodríguez-Gómez O, Abdelnour C, Jessen F, Valero S, Boada M.

J Alzheimers Dis. 2015 Sep 24;48 Suppl 1:S99-S107. doi: 10.3233/JAD-150189. Review.

PMID:
26402087
43.

Evaluation of the Effectiveness of a Psychoeducational Intervention in Treatment-Naïve Patients with Antidepressant Medication in Primary Care: A Randomized Controlled Trial.

Casañas R, Catalán R, Penadés R, Real J, Valero S, Muñoz M, Lalucat-Jo L, Casas M.

ScientificWorldJournal. 2015;2015:718607. doi: 10.1155/2015/718607. Epub 2015 Aug 25.

44.

Validation of the Spanish Version of the Face Name Associative Memory Exam (S-FNAME) in Cognitively Normal Older Individuals.

Alegret M, Valero S, Ortega G, Espinosa A, Sanabria A, Hernández I, Rodríguez O, Rosende-Roca M, Mauleón A, Vargas L, Martín E, Ruíz A, Tárraga L, Amariglio RE, Rentz DM, Boada M.

Arch Clin Neuropsychol. 2015 Nov;30(7):712-20. doi: 10.1093/arclin/acv050. Epub 2015 Aug 18.

45.

Motivational interviewing group at inpatient detoxification, its influence in maintaining abstinence and treatment retention after discharge.

Bachiller D, Grau-López L, Barral C, Daigre C, Alberich C, Rodríguez-Cintas L, Valero S, Casas M, Roncero C.

Adicciones. 2015 Jun 17;27(2):109-18.

46.

Psychiatrists admitted to a physicians' health programme.

Braquehais MD, Bel MJ, Lusilla P, Valero S, Mozo X, Nasillo V, Casas M.

Occup Med (Lond). 2015 Aug;65(6):499-501. doi: 10.1093/occmed/kqv075. Epub 2015 Jun 14.

PMID:
26078415
47.

Comorbid personality disorders in chronic fatigue syndrome patients: a marker of psychopathological severity.

Calvo N, Sáez-Francàs N, Valero S, Alegre J, Casas M.

Actas Esp Psiquiatr. 2015 Mar-Apr;43(2):58-65. Epub 2015 Mar 1.

48.

Trends in mortality due to motor vehicle traffic accident injuries between 1987 and 2011 in a Spanish region (Comunitat Valenciana).

Melchor I, Nolasco A, Moncho J, Quesada JA, Pereyra-Zamora P, García-Senchermés C, Tamayo-Fonseca N, Martínez-Andreu P, Valero S, Salinas M.

Accid Anal Prev. 2015 Apr;77:21-8. doi: 10.1016/j.aap.2015.01.023. Epub 2015 Feb 6.

PMID:
25667203
49.

Predicting treatment failure in pathological gambling: the role of personality traits.

Ramos-Grille I, Gomà-i-Freixanet M, Aragay N, Valero S, Vallès V.

Addict Behav. 2015 Apr;43:54-9. doi: 10.1016/j.addbeh.2014.12.010. Epub 2014 Dec 16.

PMID:
25555154
50.

Association between cell-bound blood amyloid-β(1-40) levels and hippocampus volume.

Sotolongo-Grau O, Pesini P, Valero S, Lafuente A, Buendía M, Pérez-Grijalba V, José IS, Ibarria M, Tejero MA, Giménez J, Hernández I, Tárraga L, Ruiz A, Boada M, Sarasa M.

Alzheimers Res Ther. 2014 Oct 20;6(5-8):56. doi: 10.1186/s13195-014-0056-3. eCollection 2014.

Supplemental Content

Loading ...
Support Center